Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
11.11. | Airdoc is committed to the early screening and predictive analysis of chronic diseases and owns the world's largest retinal image database | 236 | PR Newswire | DÜSSELDORF, Germany, Nov. 11, 2024 /PRNewswire/ -- On November 11th, at the medical exhibition in Düsseldorf, Germany, Airdoc shone brightly with its AI fundus camera 16H. Airdoc is a medical... ► Artikel lesen | |
18.10. | AIRDOC-B (02251): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 1 | HKEx | ||
18.10. | AIRDOC-B (02251): POLL RESULTS OF THE 2024 FIRST EXTRAORDINARY GENERAL MEETING | 2 | HKEx | ||
16.10. | AIRDOC-B (02251): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL REPORT OF THE COMPANY FOR THE YEAR ENDED DECEMBER 31, 2023 | - | HKEx | ||
27.09. | AIRDOC-B (02251): FORM OF PROXY FOR USE AT THE 2024 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON FRIDAY, OCTOBER 18, 2024 | - | HKEx | ||
27.09. | AIRDOC-B (02251): NOTICE OF THE EXTRAORDINARY GENERAL MEETING | - | HKEx | ||
27.09. | AIRDOC-B (02251): 2024 FIRST EGM CIRCULAR | - | HKEx | ||
26.09. | AIRDOC-B (02251): 2024 INTERIM REPORT | 1 | HKEx | ||
BEIJING AIRDOC TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
20.09. | AIRDOC-B (02251): PROPOSED APPOINTMENT OF A DIRECTOR | 1 | HKEx | ||
30.08. | EQS Newswire: Beijing Airdoc Technology Co., Ltd.: Airdoc Technology 2024 Interim Results: Solid Growth in Revenue and Gross Profit | 296 | EQS Group (EN) | EQS Newswire / 30/08/2024 / 11:52 UTC+8
On August 28, Airdoc Technology (2251.HK) announced its 2024 interim results, demonstrating continued solid growth.
In the first half of 2024,... ► Artikel lesen | |
28.08. | AIRDOC-B (02251): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | - | HKEx | ||
28.08. | AIRDOC-B (02251): RESIGNATION OF A DIRECTOR | - | HKEx | ||
28.08. | AIRDOC-B (02251): PROPOSED CHANGE IN USE OF PROCEEDS AND 2024 H SHARE FULL CIRCULATION | - | HKEx | ||
28.08. | AIRDOC-B (02251): PROPOSED ADOPTION OF THE 2024 EQUITY INCENTIVE SCHEME AND PROPOSED AUTHORIZATION TO THE BOARD AND/OR ITS AUTHORIZED PERSONS TO HANDLE ... | - | HKEx | ||
28.08. | AIRDOC-B (02251): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024 | - | HKEx | ||
16.08. | AIRDOC-B (02251): DATE OF BOARD MEETING | - | HKEx | ||
26.06. | AIRDOC-B (02251): POLL RESULTS OF THE 2023 ANNUAL GENERAL MEETING | 1 | HKEx | ||
10.04. | Beijing Airdoc Technology Co., Ltd.: Airdoc Technology (02251.HK) achieved remarkable success in 2023, accelerating its commercialization in an unparalleled way | 308 | EQS Group (EN) | EQS Newswire / 10/04/2024 / 17:58 UTC+8
Airdoc Technology (02251.HK) achieved remarkable success in 2023, accelerating its commercialization in an unparalleled way
As a leading medical AI... ► Artikel lesen | |
02.04. | Beijing Airdoc Technology Co., Ltd.: Airdoc Technology Unveils 2023 Financial Highlights, Revenue by 79%, Serving 6.83 Million cases | 538 | EQS Group (EN) | EQS Newswire / 02/04/2024 / 09:53 UTC+8
Airdoc Technology Unveils 2023 Financial Highlights, Revenue by 79%, Serving 6.83 Million cases
On March 27, medical artificial intelligence company... ► Artikel lesen | |
22.01. | Beijing Airdoc Technology Co., Ltd.: Airdoc Technology (2251.HK) Receives EU CE MDR Certification, Securing Market Access in Multiple Countries | 432 | EQS Group (EN) | EQS Newswire / 22/01/2024 / 09:42 UTC+8
Airdoc Technology (2251.HK) Receives EU CE MDR Certification, Securing Market Access in Multiple Countries
On January 8th, Airdoc Technology announced... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 33,310 | +1,59 % | WARBURG RESEARCH stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Das Analysehaus Warburg Research hat das Kursziel für Fresenius von 44 auf 42 Euro gesenkt, aber die Einstufung auf "Buy" belassen. "Nächster Schritt: Revitalisierung",... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 49,800 | +1,36 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers mit einem Kursziel von 60 Euro auf "Buy" belassen. Das China-Geschäft bleibe eine "Wildcard", schrieb... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 42,250 | +1,95 % | GOLDMAN SACHS stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für FMC von 49 auf 52 Euro angehoben und die Einstufung auf "Buy" belassen. Die Ergebnisse des dritten Quartals seien... ► Artikel lesen | |
GERRESHEIMER | 73,85 | +4,83 % | Neue 12,00% Aktienanleihe mit Barriere auf Gerresheimer in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VC8M4H1/ WKN VC8M4H) mit Barriere auf die Aktie von Gerresheimer... ► Artikel lesen | |
CARL ZEISS MEDITEC | 55,45 | +1,46 % | Carl Zeiss Meditec Aktie: Am Abgrund? | Die Aktie von Carl Zeiss Meditec erlebte am Freitag einen weiteren Rückschlag an der Börse. Im XETRA-Handel verzeichnete das Papier des Medizintechnikunternehmens deutliche Einbußen und fiel zeitweise... ► Artikel lesen | |
PROGYNY | 15,440 | +3,17 % | Progyny, Inc. Announces Third Quarter 2024 Results | Sales Season Yields Over 80 New Clients, 1.1 Million New Covered LivesSelected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner1.5 Million Lives Adopt Newest... ► Artikel lesen | |
ECKERT & ZIEGLER | 39,880 | +7,84 % | HAUCK AUFHÄUSER INVESTMENT BANKING stuft ECKERT & ZIEGLER auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Hauck Aufhäuser Investment Banking hat die Einstufung für Eckert & Ziegler mit einem Kursziel von 55 Euro auf "Buy" belassen. Das Auftragsbuch erscheine vielversprechend... ► Artikel lesen | |
TEMPUS AI | 58,59 | +11,64 % | Cathie Wood's ARK buys Tempus AI stock, sells Exact Sciences | ||
GENEDX | 78,64 | +9,18 % | GeneDx Holdings Corp. (NASDAQ:WGS) Major Shareholder Sells $8,973,629.96 in Stock | ||
PROCEPT BIOROBOTICS | 93,60 | -0,90 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
HIMS & HERS HEALTH | 24,240 | -0,37 % | Hims & Hers New Growth Category Is a Huge Surprise | ||
INTUITIVE SURGICAL | 525,50 | -0,15 % | Intuitive Surgical-Aktie erreicht 52-Wochen-Hoch bei 552 US-Dollar | ||
TALKSPACE | 3,450 | +4,23 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 12,045 | -0,45 % | Alignment Healthcare Reports Third Quarter 2024 Results | Reports $692.4 million in total revenue, up 51.6% year-over-year Increases Medicare Advantage membership, up 57.7% year-over-year to approximately 182,300 members, beating third-quarter and year-end... ► Artikel lesen | |
UNITEDHEALTH | 567,10 | 0,00 % | UnitedHealth Group: Neues Allzeithoch voraus! | UnitedHealth Group-Aktien konnten am Mittwoch zulegen und sind zum Redaktionsschluss mit einem Tagesgewinn von 2,93 Prozent der Top-Performer im Dow Jones. Aktuell notiert die Aktie bei 594,57 USD,... ► Artikel lesen |